EXHIBIT 4(ii) AMENDMENT TO THE SUBSCRIPTION AGREEMENTSubscription Agreement • October 5th, 2004 • Alpharx Inc • Pharmaceutical preparations
Contract Type FiledOctober 5th, 2004 Company IndustryThe undersigned, as a signatory to a subscription agreement with AlphaRx, Inc., executed in conjunction with that certain offering of units, consisting of one share of AlphaRx's common stock and one warrant for one additional share of AlphaRx's common stock, for up to $5,000,000 (the "Agreement") for good and valuable consideration, the adequacy and sufficiency of which is hereby acknowledged, does hereby agree that the deadline for the final closing on page 3 of the Agreement is hereby amended from August 15, 2004 to September 30, 2004.
AMENDMENT TO THE SUBSCRIPTION AGREEMENT JULY 19, 2004 The undersigned, as a signatory to a subscription agreement with AlphaRx, Inc., executed in conjunction with that certain offering of units, consisting of one share of AlphaRx's common stock and...Subscription Agreement • September 30th, 2004 • Alpharx Inc • Pharmaceutical preparations
Contract Type FiledSeptember 30th, 2004 Company IndustryThe undersigned, as a signatory to a subscription agreement with AlphaRx, Inc., executed in conjunction with that certain offering of units, consisting of one share of AlphaRx's common stock and one warrant for one additional share of AlphaRx's common stock, for up to $5,000,000 (the "Agreement") for good and valuable consideration, the adequacy and sufficiency of which is hereby acknowledged, does hereby agree that the deadline for the final closing on page 3 of the Agreement is hereby amended from August 15, 2004 to September 30, 2004.
AMENDMENT TO THE SUBSCRIPTION AGREEMENTSubscription Agreement • September 8th, 2004 • Alpharx Inc • Pharmaceutical preparations
Contract Type FiledSeptember 8th, 2004 Company IndustryThe undersigned, as a signatory to a subscription agreement with AlphaRx, Inc., executed in conjunction with that certain offering of units, consisting of one share of AlphaRx's common stock and one warrant for one additional share of AlphaRx's common stock, for up to $5,000,000 (the "Agreement") for good and valuable consideration, the adequacy and sufficiency of which is hereby acknowledged, does hereby agree that the deadline for the final closing on page 3 of the Agreement is hereby amended from August 15, 2004 to September 30, 2004.